Literature DB >> 3190200

Influence of hydrocortisone on gentamicin-induced nephrotoxicity in rats.

D Beauchamp1, M Pettigrew.   

Abstract

Many risk factors associated with aminoglycoside nephrotoxicity have been identified in humans and experimental animals. They include an initial high rate of creatinine clearance, high initial peak levels in serum, age, sex, duration of therapy, liver disease, and renal infection. The concomitant administration of steroids has never been investigated. We evaluated the role of hydrocortisone on gentamicin-induced nephroxicity in a model of infused rats. We showed that hydrocortisone given over 3 days after the infusion did not modify the gentamicin half-life in the renal cortex, gentamicin-induced lysosomal phospholipidosis, or histopathology but did reduce significantly the 3H/DNA ratio on day 4 after gentamicin infusion. We concluded that hydrocortisone interferes with the postnecrotic cellular regeneration process, an important step that is responsible for the recovery of normal kidney structure following toxic injuries associated with aminoglycoside therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190200      PMCID: PMC172331          DOI: 10.1128/AAC.32.7.992

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Action of hydrocortisone on cells in tissue culture.

Authors:  H GROSSFELD; C RAGAN
Journal:  Proc Soc Exp Biol Med       Date:  1954-05

2.  The pathology of acute renal failure due to interstitial nephritis in man with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity.

Authors:  O Kourilsky; K Solez; L Morel-Maroger; A Whelton; P Duhoux; J D Sraer
Journal:  Medicine (Baltimore)       Date:  1982-07       Impact factor: 1.889

3.  Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity.

Authors:  W M Bennett; R A Parker; W C Elliott; D N Gilbert; D C Houghton
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

4.  Effect of aging on gentamicin nephrotoxicity and pharmacokinetics in rats.

Authors:  D N McMartin; S G Engel
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1982-11

5.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

6.  Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.

Authors:  G Laurent; M B Carlier; B Rollman; F Van Hoof; P Tulkens
Journal:  Biochem Pharmacol       Date:  1982-12-01       Impact factor: 5.858

7.  Risk factors for nephrotoxicity in patients treated with aminoglycosides.

Authors:  R D Moore; C R Smith; J J Lipsky; E D Mellits; P S Lietman
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

8.  Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats.

Authors:  R Marre; N Tarara; T Louton; K Sack
Journal:  Eur J Pediatr       Date:  1980       Impact factor: 3.183

9.  A model for predicting nephrotoxicity in patients treated with aminoglycosides.

Authors:  C L Sawyers; R D Moore; S A Lerner; C R Smith
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

10.  Aminoglycoside accumulation kinetics in rat renal parenchyma.

Authors:  G R Aronoff; S T Pottratz; M E Brier; N E Walker; N S Fineberg; M D Glant; F C Luft
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

View more
  3 in total

Review 1.  Aminoglycoside therapy. Current use and future prospects.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1990-06-22

2.  Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  M Jullien; G Thériault; M G Bergeron; D Beauchamp
Journal:  Can J Infect Dis       Date:  1990

3.  Ceftriaxone protects against tobramycin nephrotoxicity.

Authors:  D Beauchamp; G Thériault; L Grenier; P Gourde; S Perron; Y Bergeron; L Fontaine; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.